These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9807841)

  • 1. Designing ribozymes for the inhibition of gene expression.
    Bramlage B; Luzi E; Eckstein F
    Trends Biotechnol; 1998 Oct; 16(10):434-8. PubMed ID: 9807841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-gene therapy: the use of ribozymes to inhibit gene function.
    Couture LA; Stinchcomb DT
    Trends Genet; 1996 Dec; 12(12):510-5. PubMed ID: 9257533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gene expression with ribozymes.
    Marschall P; Thomson JB; Eckstein F
    Cell Mol Neurobiol; 1994 Oct; 14(5):523-38. PubMed ID: 7621511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hammerhead ribozymes for target validation.
    Goodchild J
    Expert Opin Ther Targets; 2002 Apr; 6(2):235-47. PubMed ID: 12223083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
    Liu J; Timmers AM; Lewin AS; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous application of ribozymes for inhibiting gene expression.
    Eckstein F
    Ciba Found Symp; 1997; 209():207-12; discussion 212-7. PubMed ID: 9383578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tissue factor gene induction and activity using a hairpin ribozyme.
    Cavusoglu E; Chen I; Rappaport J; Marmur JD
    Circulation; 2002 May; 105(19):2282-7. PubMed ID: 12010911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral ribozymes. New jobs for ancient molecules.
    Menke A; Hobom G
    Mol Biotechnol; 1997 Aug; 8(1):17-33. PubMed ID: 9327395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous cellular delivery of ribozymes and ribozyme encoding DNAs.
    Castanotto D; Bertrand E; Rossi J
    Methods Mol Biol; 1997; 74():429-39. PubMed ID: 9204458
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.
    Beger C; Pierce LN; Kruger M; Marcusson EG; Robbins JM; Welcsh P; Welch PJ; Welte K; King MC; Barber JR; Wong-Staal F
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):130-5. PubMed ID: 11136250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
    Blalock TD; Yuan R; Lewin AS; Schultz GS
    Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly motif- and organism-dependent effects of naturally occurring hammerhead ribozyme sequences on gene expression.
    Wurmthaler LA; Klauser B; Hartig JS
    RNA Biol; 2018 Feb; 15(2):231-241. PubMed ID: 29106331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.